TABAGISMO NO PERIOPERATÓRIO
Palavras-chave:
Tabagismo. Período Perioperatório. Complicações Pós-Operatórias. Abandono do uso do Tabaco.Resumo
Este trabalho visa produzir uma revisão computadorizada da literatura em busca das atualizações referente a relação do cigarro e as complicações operatórias, com foco na ferida cirúrgica, seu impacto nas cirurgias eletivas, o tempo mínimo de retirada e as técnicas existentes, visando melhorar o peri-operatório. Realizado uma revisão computadorizada da literatura com buscas por artigos em base de dados (Cochrane library, web of Science, scielo, medline, pubmed, Cochrane libary). Existe suficiente evidência para determinar os malefícios e os piores desfechos associados ao tabaco nos pacientes cirúrgicos, todos os trabalhos mostraram benefícios com abstinência a partir de 3 a 8 semanas, sem malefícios com retirada em tempo menor. No pós-operatório indica-se mínimo 2 a 4 semanas. A Terapia Cognitivo-Comportamental mostrou-se como método mais eficiente seguida pela farmacológica. O encaminhamento e indicação por parte do cirurgião para terapia psicológica e farmacológica deve ser rotineira.
Referências
BRASIL. ANVISA. Agência Nacional de Vigilância Sanitária. SIA Trecho 5, Área especial 57, Lote 200, de 2014. A Anvisa e o controle dos produtos derivados do tabaco. ANVISA Publicações Eletrônicas, 2014. Disponível em: <http://portal.anvisa.gov.br/documents/106510/106594/A+Anvisa+e+o+Controle+dos+Produtos+Derivados+do+Tabaco/4af73983-9d76-4af4-93c0-e35f153a18a7>. Acesso em: 26/09/2016.
http://www.inca.gov.br/releases/press_release_view_arq.asp?ID=1493
Djordjevic MV, Sigountos CW, Hoffmann D, Brunnemann KD, Kagan MR, Bush LP, et al. Assessment of major carcinogens and alkaloids in the tobacco and mainstream smoke of USSR ciga- rettes. Int J Cancer J 1991;47:348—51. (8)
Chang LD, Buncke G, Slezak S, Buncke HJ. Cigarette smoking, plastic surgery, and microsurgery. J Reconstr Microsurg 1996;12:467—74. (9)
Krupski WC. The peripheral vascular consequences of smoking. Ann Vasc Surg 1991;5:291—304. (13)
KhullarD,MaaJ.Theimpactofsmokingonsurgicaloutcomes.J Am Coll Surg 2012;215:418—26. (16)
Sørensen LT. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg 2012;255:1069—79. (17)
Ernst E. Haemorheological consequences of chronic cigarette smoking. J Cardiovasc Risk 1995;2:435—9.
(27)
Krueger JK, Rohrich RJ. Clearing the smoke: the scientific rationale for tobacco abstention with plastic surgery. Plast Reconstr Surg 2001;108:1063—73. (15)
Guerin MR. In: Chemical composition of cigarette smoke Banbury report A safe cigarette? Gori GB, Bock FG, editor. Cold Spring Harbour Laboratory, New York; 1980. pp. 191–204.
Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med. 1995;152:609–612. [PubMed]
Yates DH, Breen H, Thomas PS. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects. Am J Respir Crit Care Med. 2001;164(6):1043–1046. [PubMed]
Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol. 1998;19(5):819–825. [PubMed]
Toda N, Toda H. Nitric oxide-mediated blood flow regulation as affected by smoking and nicotine. Eur J Pharmacol 2010;649: 1—13.
(30)
Sørensen LT, Toft BG, Rygaard J, Ladelund S, Paddon M, James T, et al. Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism. Surgery 2010;148:982—90.
Zevin S, Gourlay SG, Benowitz NL. Clinical pharmacology of nicotine. Clin Dermatol 1998;16:557—64.
(37)
Sørensen LT, Jørgensen S, Petersen LJ, Hemmingsen U, Bülow J, Loft S, et al. Acute effects of nicotine and smoking on blood flow, tissue oxygen, and aerobe metabolism of the skin and subcutis. J Surg Res 2009;152:224—30.
(39)
Kambam JR, Chen LH, Hyman SA. Effect of short-term smoking halt on carboxyhemoglobin levels and P50 values. Anesth Analg 1986;65:1186—8. (40)
Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med 2011;124: 144—154.e8.
(64)
Warner DO. Perioperative abstinence from cigarettes: physio- logic and clinical consequences. Anesthesiology, 2006;104:
—67.
(71)
DiClemente CC, Prochaska JO. Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance. Addict Behav. 1982;7(2):133-42. (SBPT 2009 15)
Brasil. Ministério da Saúde. Ajudando seu paciente a deixar de fumar. Rio de Janeiro: INCA, 1997. (SBPT)
Sardinha A, Oliva AD, D'Augustin J, Ribeiro F, Falcone EM. O. Intervenção Cognitivo-Comportamental com grupos para o abandono do cigarro. Rev. Bras. Ter. Cogn. 2005;1(1):83-90. (SBPT)
Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146. Update of: Cochrane Database Syst Rev. 2004;(3):CD000146. (SBPT 38)
Bolliger CT, van Biljon X, Axelsson A. A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy. Respiration. 2007;74(2):196-201. (SBPT 46).
Balfour DJ. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. Int J Clin Pract. 2001;55(1):53-7. (SBPT 55)
Jorenby D. Clinical efficacy of bupropion in the management of smoking cessation. Drugs. 2002;62(Suppl 2):25-35. (SBPT 56)
Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD000031. (SBPT 54)
Foulds J. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. Int J Clin Pract. 2006;60(5):571-6. (SBPT 60)
Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48(10):3474-7. (SBPT 61)
Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD006103. (SBPT 63)
Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):64-71. (64 SBPT)
hullarD,MaaJ. Theimpactofsmokingonsurgicaloutcomes.J Am Coll Surg 2012;215:418—26. (16)
Cruz MS, Gonc?alves MF. O papel do enfermeiro no Programa Nacional de Controle do Tabagismo. Rev Bras Cancerol. 2010;56(1):35-42.
Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006;15:352–358
Wong J, Lam DP, Abrishami A, Chan MT, Chung F. Short-term preoperative smoking cessa on and postoperative complications: a systema c review and meta-analysis. Can J Anesth. 2012;59(3):268-79
Pluvy I, et al. Smoking and plastic surgery, part I. Pathophysiological aspects: Update and proposed recommendations. Ann Chir Plast Esthet (2014), http://dx.doi.org/10.1016/j.anplas.2014.06.011
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2018 Arquivos Catarinenses de Medicina
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
